FDA.reportPublic FDA data

vorasidenib (as vorasidenib citrate) 40 MG Oral Tablet

RxCUI
2690661
RxNorm name
vorasidenib (as vorasidenib citrate) 40 MG Oral Tablet
Display name
vorasidenib (as vorasidenib citrate) 40 MG Oral Tablet
Full name
vorasidenib (as vorasidenib citrate) 40 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
31405fee-55b7-4857-987e-2724ee76be84vorasidenib 40 MG Oral Tablet [PSN] · vorasidenib 40 MG Oral Tablet [SCD] · vorasidenib (as vorasidenib citrate) 40 MG Oral Tablet [SY]34These highlights do not include all the information needed to use VORANIGO safely and effectively. See full prescribing information for VORANIGO. VORANIGO ® (vorasidenib) tablets, for oral use Initial U.S. Approval: 202420250408